Breaking News
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
Compassion meditation training may increase brain’s resilience to suffering of other people

Compassion meditation training may increase brain’s resilience to suffering of other people

image_pdfDownload PDFimage_print

It can be distressing to witness the pain of family, friends or even strangers going through a hard time. But what if, just like strengthening a muscle or learning a new hobby, we could train ourselves to be more compassionate and calm in the face of others’ suffering?

That is the question behind research from the University of Wisconsin-Madison, and a new study suggests that as little as two weeks of compassion meditation training — intentionally cultivating positive wishes to understand and relieve the suffering of others — may reduce the distress a person feels when witnessing another’s suffering. It may also improve their ability and likelihood to respond with compassion.

The findings, published May 22 in the journal Frontiers in Psychology, may have implications for professions in which people routinely work with others who are suffering, like doctors, law enforcement officers and first responders who experience high levels of distress or empathic burnout.

“Compassion meditation may shift habits of becoming overly distressed when we encounter another’s pain,” says Helen Weng, assistant professor of psychiatry at the Osher Center for Integrative Medicine at the University of California, San Francisco. She led the research while a graduate student at the Center for Healthy Minds at UW-Madison. “People can learn a calmer and more balanced response when they see someone suffering, even when they are attending more to suffering.”

For the study, 24 participants were randomly assigned and trained to do either 30 minutes of compassion meditation or reappraisal training (re-interpreting personally stressful events to decrease negative emotions) every day for two weeks.

The compassion meditation group was trained to visualize people when they were suffering and practice noticing their own personal reactions in a calm and nonjudgmental way. Focusing on a loved one, on themselves, on a stranger, and on someone with whom they had conflict, they also practiced caring for and wishing to help the other person.

In this way, practicing compassion meditation was like exercising a muscle by gradually increasing the “weight” of the relationship with each person considered.

Both groups received brain scans before they were trained and after two weeks of practice to see whether compassion meditation made it easier for those trained to actually look at a suffering person. Humans are visually attentive as a species, Weng says, and looking at someone is a critical first step in determining if they’re in need.

“Your eyes are a window into what you care about,” she says. “We wanted to know: Does looking more at suffering in the mind’s eye translate into looking more at suffering out in the real world, and can this be done with less distress?”

While in the brain scanner, before and after two weeks of practice, the participants viewed neutral images of strangers as well as emotionally evocative images of people suffering — like a burn victim or crying child. They were instructed to react to the images as they normally would and to make use of their new training.

For instance, people in the compassion training group practiced compassion toward individuals in the images, having thoughts like: “May this person be happy and free from suffering.” The reappraisal group reframed the situation: “This person is an actor and isn’t really suffering.”

The researchers used eye-tracking techniques to record where people spent the most time gazing at each image, whether it was on areas of the image that were more negative — such as the faces of those in suffering — or on less emotionally charged parts of the image. They also compared this to how much time each participant looked at the socially relevant areas of neutral images, like the face of a person walking down the street.

The research team found that the people who had practiced compassion meditation tended to look more directly at suffering in the negative images relative to the neutral photos. They also showed less activity in the amygdala, insula and orbitofrontal cortex — areas of the brain that are usually more active when experiencing emotional distress and might lead to a withdrawal response and averted gaze.

This finding was not present in the reappraisal group, and the results suggest compassion could be a mechanism through which people may become calmer in the face of suffering.

“We communicate a lot with our eyes, and this research suggests that compassion training has an impact on the body and can actually shift where you direct your visual attention when you see others in pain,” says Weng.

Compassion meditation slows things down so people can practice being more calm, notice the feelings that arise and learn to be less reactive, she adds. “This gives you more mental space to focus on the other person, to practice wishing kindness and wanting them to be well, and I think both parts are really important for effectively responding to people suffering.”

Though the results are exciting, Weng says a larger and more diverse sample of people should be involved in a repeated study. The study was also performed with people who had never meditated before and it’s not yet clear whether scientists would find more pronounced results in people who already had extensive compassion meditation practice.

Compassion meditation could also be used as a strategy for working with people with conditions that affect how comfortable they are making eye contact with others, says Richard Davidson, founder of the Center for Healthy Minds and senior author of the study.

“The pattern of these findings — an increase in looking at suffering while simultaneously down-regulating neural circuits associated with negative emotion — is a winning combination that may be beneficial for a wide range of conditions including autism and social anxiety disorder in which gaze aversion and social discomfort are hallmark signs,” he adds.

Source:

Training compassion ‘muscle’ may boost brain’s resilience to others’ suffering

Tagged with:

About author

Related Articles